JPH0696521B2 - 眼局所投与用眼圧降下剤 - Google Patents

眼局所投与用眼圧降下剤

Info

Publication number
JPH0696521B2
JPH0696521B2 JP61020361A JP2036186A JPH0696521B2 JP H0696521 B2 JPH0696521 B2 JP H0696521B2 JP 61020361 A JP61020361 A JP 61020361A JP 2036186 A JP2036186 A JP 2036186A JP H0696521 B2 JPH0696521 B2 JP H0696521B2
Authority
JP
Japan
Prior art keywords
intraocular pressure
compound
ocular
topical
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61020361A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62178514A (ja
Inventor
佑二郎 山本
貴裕 小河
義和 栗林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Priority to JP61020361A priority Critical patent/JPH0696521B2/ja
Priority to US07/003,285 priority patent/US4826879A/en
Priority to ES87100931T priority patent/ES2032390T3/es
Priority to EP87100931A priority patent/EP0235544B1/en
Priority to DE8787100931T priority patent/DE3777858D1/de
Priority to CA000528282A priority patent/CA1282704C/en
Priority to HU87269A priority patent/HU199285B/hu
Priority to AU68139/87A priority patent/AU591228B2/en
Publication of JPS62178514A publication Critical patent/JPS62178514A/ja
Priority to GR920400746T priority patent/GR3004513T3/el
Publication of JPH0696521B2 publication Critical patent/JPH0696521B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP61020361A 1986-01-31 1986-01-31 眼局所投与用眼圧降下剤 Expired - Lifetime JPH0696521B2 (ja)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP61020361A JPH0696521B2 (ja) 1986-01-31 1986-01-31 眼局所投与用眼圧降下剤
US07/003,285 US4826879A (en) 1986-01-31 1987-01-14 Intraocular pressure lowering composition for topical use
ES87100931T ES2032390T3 (es) 1986-01-31 1987-01-23 Composicion antihipertensiva ocular para uso topico. (reserva del art. 167.2 cpe).
EP87100931A EP0235544B1 (en) 1986-01-31 1987-01-23 Ocular antihypertensive composition for topical use
DE8787100931T DE3777858D1 (de) 1986-01-31 1987-01-23 Okulare antihypertensive zusammensetzung zur topischen verwendung.
CA000528282A CA1282704C (en) 1986-01-31 1987-01-27 Ocular antihypertensive composition for topical use
HU87269A HU199285B (en) 1986-01-31 1987-01-29 Process for producing topical antihypertenzive ophthalmic compositioncontaining 2,5-dihydroxy-6-isopropyl-amino-5,6,7,8-tetrahydro-1-naphtyl-methanol or salts
AU68139/87A AU591228B2 (en) 1986-01-31 1987-01-30 Ocular antihypertensive composition for topical use
GR920400746T GR3004513T3 (US07498051-20090303-C00003.png) 1986-01-31 1992-05-07

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61020361A JPH0696521B2 (ja) 1986-01-31 1986-01-31 眼局所投与用眼圧降下剤

Publications (2)

Publication Number Publication Date
JPS62178514A JPS62178514A (ja) 1987-08-05
JPH0696521B2 true JPH0696521B2 (ja) 1994-11-30

Family

ID=12024951

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61020361A Expired - Lifetime JPH0696521B2 (ja) 1986-01-31 1986-01-31 眼局所投与用眼圧降下剤

Country Status (9)

Country Link
US (1) US4826879A (US07498051-20090303-C00003.png)
EP (1) EP0235544B1 (US07498051-20090303-C00003.png)
JP (1) JPH0696521B2 (US07498051-20090303-C00003.png)
AU (1) AU591228B2 (US07498051-20090303-C00003.png)
CA (1) CA1282704C (US07498051-20090303-C00003.png)
DE (1) DE3777858D1 (US07498051-20090303-C00003.png)
ES (1) ES2032390T3 (US07498051-20090303-C00003.png)
GR (1) GR3004513T3 (US07498051-20090303-C00003.png)
HU (1) HU199285B (US07498051-20090303-C00003.png)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306731A (en) * 1985-06-14 1994-04-26 Massachusetts Eye And Ear Infirmary Method and products for treating the eye
US5863948A (en) * 1985-06-14 1999-01-26 Massachusetts Eye And Ear Infirmary Increasing aqueous humor outflow
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5314916A (en) * 1993-04-19 1994-05-24 Alcon Laboratories, Inc. B2 adrenegic agonists and use thereof in the treatment of glaucoma
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
US6162393A (en) * 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US8557868B2 (en) * 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
US20060148665A1 (en) * 2000-11-08 2006-07-06 Bioconcept Laboratories Ophthalmic and contact lens solutions containing forms of vitamin b
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
US20060127496A1 (en) * 2000-11-08 2006-06-15 Bioconcept Laboratories L-histidine in ophthalmic solutions
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
US20070098813A1 (en) * 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions with a peroxide source and a preservative
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
US9492582B2 (en) * 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
JP4084997B2 (ja) * 2000-11-08 2008-04-30 エフエックスエス・ベンチャーズ・エルエルシー 防腐剤増強剤として単純糖類を含有する改良眼科用およびコンタクトレンズ用溶液
WO2004091438A2 (en) * 2003-04-15 2004-10-28 Fxs Ventures, Llc Improved ophthalmic and contact lens solutions containing peptides as representative enhancers
JP4778053B2 (ja) 2005-07-14 2011-09-21 リセラ，インコーポレイテッド 局所的脂肪組織処置のための徐放性増強脂肪分解処方物
MX2009004198A (es) * 2006-10-17 2009-10-19 Lithera Inc Metodos, composiciones y formulaciones para el tratamiento de enfermedad ocular tiroidea.
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
GB2487868B (en) * 2010-01-15 2014-12-10 Neothetics Inc Lyophilized cake formulations
EP2646012A4 (en) 2010-11-24 2014-12-10 Neothetics Inc MONOTHERAPEUTIC FORMULATIONS OF SELECTIVE, LIPOPHILIC AND PROLONGED BETA AGONISTS AND METHODS OF COSMETIC TREATMENT OF SILHOUETTE ADPOSITY AND REINFORCEMENT
CN103664816B (zh) * 2011-01-06 2016-03-02 中国科学院上海有机化学研究所 Hiv逆转录酶抑制剂依法韦伦类化合物的一锅法不对称合成工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826332B2 (ja) * 1974-04-25 1983-06-02 武田薬品工業株式会社 テトラロ−ルカゴウブツ ノ セイゾウホウ
JPS5833219B2 (ja) * 1974-06-12 1983-07-18 武田薬品工業株式会社 テトラロ−ルカゴウブツノ セイゾウホウ
DK254975A (da) * 1974-06-12 1975-12-13 Takeda Chemical Industries Ltd Fremgangsmade til fremstilling af aminotetralolforbindelser
JPS5283826A (en) * 1976-01-01 1977-07-13 Takeda Chem Ind Ltd Tetralol compound
US4402976A (en) * 1981-04-24 1983-09-06 E. R. Squibb & Sons, Inc. Method for treating glaucoma with systemic nadolol compositions
JPS5970653A (ja) * 1982-10-15 1984-04-21 Takeda Chem Ind Ltd 眼圧低下剤
IT1163107B (it) * 1983-02-15 1987-04-08 Simes Composizioni farmaceutiche e loro uso nel trattamento del glaucoma

Also Published As

Publication number Publication date
AU6813987A (en) 1987-08-06
AU591228B2 (en) 1989-11-30
EP0235544B1 (en) 1992-04-01
HU199285B (en) 1990-02-28
EP0235544A2 (en) 1987-09-09
EP0235544A3 (en) 1989-11-29
ES2032390T3 (es) 1996-07-16
JPS62178514A (ja) 1987-08-05
US4826879A (en) 1989-05-02
CA1282704C (en) 1991-04-09
HUT46210A (en) 1988-10-28
GR3004513T3 (US07498051-20090303-C00003.png) 1993-04-28
DE3777858D1 (de) 1992-05-07

Similar Documents

Publication Publication Date Title
JPH0696521B2 (ja) 眼局所投与用眼圧降下剤
JP2683676B2 (ja) 局所投与用炎症性疾患治療剤
CA2986839C (en) Tiotropium inhalation solution for nebulization
SK147493A3 (en) Antialergic substances for the use in ophthalmologic and otorhynologic
WO1993024121A1 (en) Remedy for glaucoma
JPH1160505A (ja) 防腐組成物
US5438060A (en) Method of reducing elevated intraocular pressure
US5049587A (en) Ophthalmic solution for intraocular pressure adjustment
US4197301A (en) Topical ophthalmic use of Prazosin
CA1139669A (en) Compositions for treating glaucoma
HUE026162T2 (en) Olopatadine preparation for topical nasal administration
EP0348527B1 (en) Antiallergic eye drop
EP0695545B1 (en) Use of diphenylethane derivatives for the manufacture of a medicament for the treatment of glaucoma
US5308849A (en) Method of reducing elevated intraocular pressure
TW304879B (US07498051-20090303-C00003.png)
US4764530A (en) Pharmaceutical compositions and their use as mydriatics
EP0728480A1 (en) Use of ifenprodil for treatment of elevated intraocular pressure
EP0277814B1 (en) Anti-glaucoma use of trifluoromethanesulfonamide
US5428030A (en) Method of reducing elevated intraocular pressure
US5093348A (en) Pharmaceutical composition for topical ophthalmic use having improved local tolerability
JPH1036255A (ja) 眼圧降下用点眼剤
WO2000043015A1 (fr) Gouttes ophtalmologiques
EP0719553A1 (en) Pharmaceutical composition for topical administration to the eye for treating allergic conjunctivitis
JPH0778022B2 (ja) 緑内障治療剤
JPH04134029A (ja) 緑内障治療剤